Diagnostic Testing for Hepatitis C Virus in the Era of Direct-Acting Antiviral Therapy is the twelfth of 12 programs in AACC’s “Cutting Edge Technologies, Common Sense Solutions” webinar series. Register for this webinar and hear an expert molecular biologist describe the challenges, opportunities and changes new screening recommendations and new direct-acting antiviral therapies are bringing to labs that perform HCV testing.
Support for this webinar is provided, in part, by educational grants from Roche Diagnostics Corporation.